Back to top
more

WAVE Life Sciences (WVE)

(Delayed Data from NSDQ)

$4.66 USD

4.66
407,036

-0.08 (-1.69%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $4.67 +0.01 (0.21%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (75 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for WVE

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

WAVE Life Sciences Ltd. [WVE]

Reports for Purchase

Showing records 21 - 40 ( 57 total )

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 21

09/28/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for WVE

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 22

08/06/2021

Company Report

Pages: 7

Preclinical Data Highlights Frame Clinical Expectations for 2022; Reit Buy and $10 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 23

06/03/2021

Daily Note

Pages: 4

Under the Radar - Wave''s "ADAR" Program Gives PRISM Additional Depth

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 10.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 24

05/14/2021

Company Report

Pages: 8

PRISM Platform Charts Course for ALS and FTD, While Revisiting HD and DMD; Reit Buy and $10 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 25

03/30/2021

Company Report

Pages: 7

PRECISION-HD Trials Fail to Deliver in HD, While WVE-003 Aims for a Win; Reit Buy and Lowering Our PT to $10

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 26

03/05/2021

Company Report

Pages: 7

PRECISION HD-1 and HD-2 Data Imminent; Multiple PN-Chemistry Assets Set to Enter the Clinic in 2021;Reit Buy and $20 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 27

12/15/2020

Company Report

Pages: 16

Assuming Coverage With Buy and $20 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 28

09/01/2020

Company Report

Pages: 9

In the Meantime, a Look Down the Pipeline

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHATTOPADHYAY D

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 29

08/11/2020

Company Report

Pages: 9

2Q20 Update; HD-1 and 2 Readouts Now Anticipated During 1Q21

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHATTOPADHYAY D

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 30

05/12/2020

Company Report

Pages: 9

On Track to Unveil PRECISION HD-1 and HD-2 During 2H20

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHATTOPADHYAY D

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 31

03/23/2020

Industry Report

Pages: 4

Revisiting 2020 Catalyst Calendar

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHATTOPADHYAY D

Price: 10.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 32

03/03/2020

Company Report

Pages: 9

2H20 Can''t Arrive Fast Enough

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHATTOPADHYAY D

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 33

03/02/2020

Industry Report

Pages: 7

From TINA to Cash Is King and Other Musings

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 34

02/21/2020

Industry Report

Pages: 7

Bringing a Wallet to a Hammer and Sickle Fight, and Other Tidbits

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHATTOPADHYAY D

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 35

02/14/2020

Industry Report

Pages: 7

Runners up Is the New Killing It, and Other Tidbits

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHATTOPADHYAY D

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 36

02/07/2020

Daily Note

Pages: 9

LetÂ’s Caucus, or Never Again; In an Otherwise Ho-Hum Earnings Week

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHATTOPADHYAY D

Price: 25.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 37

01/09/2020

Daily Note

Pages: 18

2020 Catalyst Calendar and Top Picks Across Mid, Small, and Micro Caps

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHATTOPADHYAY D

Price: 50.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 38

01/02/2020

Company Report

Pages: 16

Not Throwing in the Towel Just Yet; Target Lowered to $20

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHATTOPADHYAY D

Price: 50.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 39

12/17/2019

Company Report

Pages: 16

Thoughts Into the Watershed PRECISION HD2 Readout

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHATTOPADHYAY D

Price: 50.00

Research Provided by a Third Party

Company: WAVE Life Sciences Ltd.

Industry: Medical - Biomedical and Genetics

Record: 40

11/06/2019

Company Report

Pages: 9

Reiterates DMD and HD Data During 4Q19: Set Up to Be the Biggest Mover in Our Universe

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHATTOPADHYAY D

Price: 25.00

Research Provided by a Third Party